These findings suggest that STAT3 signaling plays a crucial role in the functional significance of SIX1 in thyroid cancer, and it may raise a possibility that JAK/STAT3 inhibitors can be treated in those PTC patients with high expression of SIX1. Here, STAT3 is linked to thyroid cancer.